Results 81 to 90 of about 258,912 (200)

Clozapine:norclozapine ratio as a marker of metabolic risk and therapeutic response and effect of valproate on clozapine levels

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Clozapine is the most effective antipsychotic in treatment‐resistant schizophrenia. Clozapine causes weight gain and increased diabetes risk. The role of its metabolite norclozapine and clozapine:norclozapine ratio (CLZ/NCLZ) in metabolic effects has been debated.
Susanna Maria Rask   +6 more
wiley   +1 more source

On the importance of including both sexes in animal studies – insights from home‐cage monitoring

open access: yesBiological Reviews, EarlyView.
ABSTRACT A review of behavioural studies using home‐cage monitoring (HCM) systems revealed that over 61% of studies used only male subjects, with only 24% including both sexes, despite evidence of substantial behavioural differences between male and female animals. This bias could influence the outcomes of biomedical research.
Maša Čater   +12 more
wiley   +1 more source

Applying the Rules of Evidence to Expert Testimony About Risk

open access: yesBehavioral Sciences &the Law, EarlyView.
ABSTRACT Expert opinion about dangerousness or risk is common at sentencing, criminal commitment proceedings and some types of pretrial detention hearings. This article argues that such evidence must be (1) “material” (logically relevant, empirically generalizable, and epistemologically germane), (2) “probative” (a measure of accuracy, which is ...
Christopher Slobogin
wiley   +1 more source

Depression, Anxiety and Criminal Behaviour Between Ages 32 and 48: A Propensity Score Matching Analysis From the Cambridge Study in Delinquent Development

open access: yesCriminal Behaviour and Mental Health, EarlyView.
ABSTRACT Background Depression, anxiety and criminal behaviour are often correlated, but the direction and nature of these associations remain contested. Aims To investigate the temporal relationships between depression and/or anxiety and criminal behaviour at age 32 and depression and/or anxiety and criminal behaviour at age 48.
Kim Reising, Maria M. Ttofi
wiley   +1 more source

Mental Health and Serious Drug Crime: A Case–Control Study

open access: yesCriminal Behaviour and Mental Health, EarlyView.
ABSTRACT Background Serious drug crime involves a high level of risk and is often characterised as requiring a network of suitable and trustworthy collaborators. Although prior studies have focused on the importance of economic, social and work‐related factors for involvement in such crime, there has been less research into the mental health of the ...
Morten Hesse   +4 more
wiley   +1 more source

Experiences of Prisoners Living With Mental Health Conditions and Seeking or Receiving Mental Health Support in Prisons: An Integrative Review

open access: yesCriminal Behaviour and Mental Health, EarlyView.
ABSTRACT Background Prisoners experience poor mental health and well‐being in prison, including severe mental illnesses. However, access to mental health support and treatment in prison is limited. We conducted an integrative review to synthesise prisoners' experiences of living with mental ill health and/or seeking or receiving mental health support ...
Anne Kairu   +5 more
wiley   +1 more source

Power spectral density and the brain

open access: yesCanadian Journal of Statistics, EarlyView.
Abstract Time series from M/EEG (magneto/electroencephalography) and ECoG (electrocorticography) recordings are common sources of information about brain function. The power spectral density (PSD) preserves much of this information, up to second order. In the current decade, a burst of brain diagnostics using the slope of log(PSD) has appeared.
Priscilla E. Greenwood   +2 more
wiley   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples   +10 more
wiley   +1 more source

Psychiatric Morbidity Is Overrepresented in Young Girls at High Risk of Developing Anorexia Nervosa

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Psychiatric comorbidity frequently presents in anorexia nervosa (AN). Yet, the premorbid mental health status is relatively unknown. The aim of this study was to map out psychiatric morbidity and psychopathology among girls at familial high risk (FHR) of developing AN, thereby detecting possible underlying vulnerabilities preceding ...
Karin Dahlin   +3 more
wiley   +1 more source

When Is Improvement Possible? A Necessity‐Based Analysis of Short‐Term Eating Disorder Symptom Improvement During Inpatient Treatment

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Eating‐disorder–specific functional impairment may represent a boundary condition for treatment response, yet this possibility has rarely been examined. We investigated whether baseline functional impairment constrains short‐term eating‐disorder symptom improvement, indexed by change in EDE‐Q Global scores during inpatient treatment ...
Paolo Meneguzzo, Patrizia Todisco
wiley   +1 more source

Home - About - Disclaimer - Privacy